Norwood Financial’s Bristol-Myers Squibb BMY Stock Holding History

Norwood Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$166K	Buy	3,053 +450	+17%	+$22.9K	0.24%	85
2023 Q4	$134K	Hold	2,603	–	–	0.2%	89
2023 Q3	$151K	Sell	2,603 -95	-4%	-$5.82K	0.24%	79
2023 Q2	$173K	Buy	2,698 +898	+50%	+$60.2K	0.26%	74
2023 Q1	$125K	Hold	1,800	–	–	0.2%	87
2022 Q4	$130K	Hold	1,800	–	–	0.2%	84
2022 Q3	$128K	Hold	1,800	–	–	0.23%	80
2022 Q2	$139K	Hold	1,800	–	–	0.24%	77
2022 Q1	$131K	Hold	1,800	–	–	0.19%	84
2021 Q4	$112K	Buy	+1,800	New	+$106K	0.16%	94

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norwood Financial's BMY Position: Q1 2024 in Review

Norwood Financial increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2024, buying an estimated $22.9K and bringing the position to 3,053 shares worth $166K. The position accounts for 0.24% of the portfolio, ranked #85.

Norwood Financial first reported a position in BMY in Q4 2021 and has held it in 10 quarters since. The position peaked at $173K in Q2 2023. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Norwood Financial held 3,053 shares of Bristol-Myers Squibb worth $166K as of Q1 2024.
Norwood Financial bought 450 Bristol-Myers Squibb shares in Q1 2024, an estimated $22.9K.
Bristol-Myers Squibb made up 0.24% of Norwood Financial's portfolio in Q1 2024, its #85 holding.
Norwood Financial first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 10 quarters since.
Norwood Financial's Bristol-Myers Squibb position peaked at $173K in Q2 2023.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.